2-[(3-fluoro-1H-pyrrolo[2,3-b]pyridin-5-yl)oxy]-N-[[(3S)-3-(4-hydroxy-4-methylcyclohexyl)-5-nitro-3,4-dihydro-2H-1,4-benzoxazin-7-yl]sulfonyl]-4-[2-[(3R,4S)-3-(2-propan-2-ylphenyl)-1-propan-2-ylsulfonylpiperidin-4-yl]-2,7-diazaspiro[3.5]nonan-7-yl]benzamide

C53H65FN8O10S2 — CID 168761263

IUPAC2-[(3-fluoro-1H-pyrrolo[2,3-b]pyridin-5-yl)oxy]-N-[[(3S)-3-(4-hydroxy-4-methylcyclohexyl)-5-nitro-3,4-dihydro-2H-1,4-benzoxazin-7-yl]sulfonyl]-4-[2-[(3R,4S)-3-(2-propan-2-ylphenyl)-1-propan-2-ylsulfonylpiperidin-4-yl]-2,7-diazaspiro[3.5]nonan-7-yl]benzamide
SMILESCC(C)c1ccccc1[C@@H]1CN(S(=O)(=O)C(C)C)CC[C@@H]1N1CC2(CCN(c3ccc(C(=O)NS(=O)(=O)c4cc5c(c([N+](=O)[O-])c4)N[C@@H](C4CCC(C)(O)CC4)CO5)c(Oc4cnc5[nH]cc(F)c5c4)c3)CC2)C1
InChIInChI=1S/C53H65FN8O10S2/c1-32(2)38-8-6-7-9-39(38)42-28-61(74(69,70)33(3)4)19-14-45(42)60-30-53(31-60)17-20-59(21-18-53)35-10-11-40(47(22-35)72-36-23-41-43(54)27-56-50(41)55-26-36)51(63)58-73(67,68)37-24-46(62(65)66)49-48(25-37)71-29-44(57-49)34-12-15-52(5,64)16-13-34/h6-11,22-27,32-34,42,44-45,57,64H,12-21,28-31H2,1-5H3,(H,55,56)(H,58,63)/t34?,42-,44+,45-,52?/m0/s1
InChIKeyMZNAFCBAGRREHW-JNJBWZMJSA-N
MW1057.28 g/mol
LogP8.26
Rot. Bonds13

About 2-[(3-fluoro-1H-pyrrolo[2,3-b]pyridin-5-yl)oxy]-N-[[(3S)-3-(4-hydroxy-4-methylcyclohexyl)-5-nitro-3,4-dihydro-2H-1,4-benzoxazin-7-yl]sulfonyl]-4-[2-[(3R,4S)-3-(2-propan-2-ylphenyl)-1-propan-2-ylsulfonylpiperidin-4-yl]-2,7-diazaspiro[3.5]nonan-7-yl]benzamide

2-[(3-fluoro-1H-pyrrolo[2,3-b]pyridin-5-yl)oxy]-N-[[(3S)-3-(4-hydroxy-4-methylcyclohexyl)-5-nitro-3,4-dihydro-2H-1,4-benzoxazin-7-yl]sulfonyl]-4-[2-[(3R,4S)-3-(2-propan-2-ylphenyl)-1-propan-2-ylsulfonylpiperidin-4-yl]-2,7-diazaspiro[3.5]nonan-7-yl]benzamide (PubChem CID 168761263) has the molecular formula C53H65FN8O10S2 and a molecular weight of 1057.28 g/mol. Its IUPAC name is 2-[(3-fluoro-1H-pyrrolo[2,3-b]pyridin-5-yl)oxy]-N-[[(3S)-3-(4-hydroxy-4-methylcyclohexyl)-5-nitro-3,4-dihydro-2H-1,4-benzoxazin-7-yl]sulfonyl]-4-[2-[(3R,4S)-3-(2-propan-2-ylphenyl)-1-propan-2-ylsulfonylpiperidin-4-yl]-2,7-diazaspiro[3.5]nonan-7-yl]benzamide.

Molecular Properties

Compound Name2-[(3-fluoro-1H-pyrrolo[2,3-b]pyridin-5-yl)oxy]-N-[[(3S)-3-(4-hydroxy-4-methylcyclohexyl)-5-nitro-3,4-dihydro-2H-1,4-benzoxazin-7-yl]sulfonyl]-4-[2-[(3R,4S)-3-(2-propan-2-ylphenyl)-1-propan-2-ylsulfonylpiperidin-4-yl]-2,7-diazaspiro[3.5]nonan-7-yl]benzamide
PubChem CID168761263
Molecular FormulaC53H65FN8O10S2
Molecular Weight1057.28 g/mol
Exact Mass1056.42
IUPAC Name2-[(3-fluoro-1H-pyrrolo[2,3-b]pyridin-5-yl)oxy]-N-[[(3S)-3-(4-hydroxy-4-methylcyclohexyl)-5-nitro-3,4-dihydro-2H-1,4-benzoxazin-7-yl]sulfonyl]-4-[2-[(3R,4S)-3-(2-propan-2-ylphenyl)-1-propan-2-ylsulfonylpiperidin-4-yl]-2,7-diazaspiro[3.5]nonan-7-yl]benzamide
SMILESCC(C)c1ccccc1[C@@H]1CN(S(=O)(=O)C(C)C)CC[C@@H]1N1CC2(CCN(c3ccc(C(=O)NS(=O)(=O)c4cc5c(c([N+](=O)[O-])c4)N[C@@H](C4CCC(C)(O)CC4)CO5)c(Oc4cnc5[nH]cc(F)c5c4)c3)CC2)C1
InChIInChI=1S/C53H65FN8O10S2/c1-32(2)38-8-6-7-9-39(38)42-28-61(74(69,70)33(3)4)19-14-45(42)60-30-53(31-60)17-20-59(21-18-53)35-10-11-40(47(22-35)72-36-23-41-43(54)27-56-50(41)55-26-36)51(63)58-73(67,68)37-24-46(62(65)66)49-48(25-37)71-29-44(57-49)34-12-15-52(5,64)16-13-34/h6-11,22-27,32-34,42,44-45,57,64H,12-21,28-31H2,1-5H3,(H,55,56)(H,58,63)/t34?,42-,44+,45-,52?/m0/s1
InChIKeyMZNAFCBAGRREHW-JNJBWZMJSA-N
XLogP8.26
TPSA229.64 Ų
H-Bond Donors4
H-Bond Acceptors14
Rotatable Bonds13
Heavy Atoms74
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001057.28
LogP ≤ 58.26
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1014

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze 2-[(3-fluoro-1H-pyrrolo[2,3-b]pyridin-5-yl)oxy]-N-[[(3S)-3-(4-hydroxy-4-methylcyclohexyl)-5-nitro-3,4-dihydro-2H-1,4-benzoxazin-7-yl]sulfonyl]-4-[2-[(3R,4S)-3-(2-propan-2-ylphenyl)-1-propan-2-ylsulfonylpiperidin-4-yl]-2,7-diazaspiro[3.5]nonan-7-yl]benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[(3-fluoro-1H-pyrrolo[2,3-b]pyridin-5-yl)oxy]-N-[[(3S)-3-(4-hydroxy-4-methylcyclohexyl)-5-nitro-3,4-dihydro-2H-1,4-benzoxazin-7-yl]sulfonyl]-4-[2-[(3R,4S)-3-(2-propan-2-ylphenyl)-1-propan-2-ylsulfonylpiperidin-4-yl]-2,7-diazaspiro[3.5]nonan-7-yl]benzamide?
The IUPAC name of 2-[(3-fluoro-1H-pyrrolo[2,3-b]pyridin-5-yl)oxy]-N-[[(3S)-3-(4-hydroxy-4-methylcyclohexyl)-5-nitro-3,4-dihydro-2H-1,4-benzoxazin-7-yl]sulfonyl]-4-[2-[(3R,4S)-3-(2-propan-2-ylphenyl)-1-propan-2-ylsulfonylpiperidin-4-yl]-2,7-diazaspiro[3.5]nonan-7-yl]benzamide (CID 168761263) is 2-[(3-fluoro-1H-pyrrolo[2,3-b]pyridin-5-yl)oxy]-N-[[(3S)-3-(4-hydroxy-4-methylcyclohexyl)-5-nitro-3,4-dihydro-2H-1,4-benzoxazin-7-yl]sulfonyl]-4-[2-[(3R,4S)-3-(2-propan-2-ylphenyl)-1-propan-2-ylsulfonylpiperidin-4-yl]-2,7-diazaspiro[3.5]nonan-7-yl]benzamide.
What is the SMILES notation for 2-[(3-fluoro-1H-pyrrolo[2,3-b]pyridin-5-yl)oxy]-N-[[(3S)-3-(4-hydroxy-4-methylcyclohexyl)-5-nitro-3,4-dihydro-2H-1,4-benzoxazin-7-yl]sulfonyl]-4-[2-[(3R,4S)-3-(2-propan-2-ylphenyl)-1-propan-2-ylsulfonylpiperidin-4-yl]-2,7-diazaspiro[3.5]nonan-7-yl]benzamide?
The canonical SMILES for 2-[(3-fluoro-1H-pyrrolo[2,3-b]pyridin-5-yl)oxy]-N-[[(3S)-3-(4-hydroxy-4-methylcyclohexyl)-5-nitro-3,4-dihydro-2H-1,4-benzoxazin-7-yl]sulfonyl]-4-[2-[(3R,4S)-3-(2-propan-2-ylphenyl)-1-propan-2-ylsulfonylpiperidin-4-yl]-2,7-diazaspiro[3.5]nonan-7-yl]benzamide is CC(C)c1ccccc1[C@@H]1CN(S(=O)(=O)C(C)C)CC[C@@H]1N1CC2(CCN(c3ccc(C(=O)NS(=O)(=O)c4cc5c(c([N+](=O)[O-])c4)N[C@@H](C4CCC(C)(O)CC4)CO5)c(Oc4cnc5[nH]cc(F)c5c4)c3)CC2)C1.
What is the InChIKey of 2-[(3-fluoro-1H-pyrrolo[2,3-b]pyridin-5-yl)oxy]-N-[[(3S)-3-(4-hydroxy-4-methylcyclohexyl)-5-nitro-3,4-dihydro-2H-1,4-benzoxazin-7-yl]sulfonyl]-4-[2-[(3R,4S)-3-(2-propan-2-ylphenyl)-1-propan-2-ylsulfonylpiperidin-4-yl]-2,7-diazaspiro[3.5]nonan-7-yl]benzamide?
The InChIKey is MZNAFCBAGRREHW-JNJBWZMJSA-N. The full InChI is InChI=1S/C53H65FN8O10S2/c1-32(2)38-8-6-7-9-39(38)42-28-61(74(69,70)33(3)4)19-14-45(42)60-30-53(31-60)17-20-59(21-18-53)35-10-11-40(47(22-35)72-36-23-41-43(54)27-56-50(41)55-26-36)51(63)58-73(67,68)37-24-46(62(65)66)49-48(25-37)71-29-44(57-49)34-12-15-52(5,64)16-13-34/h6-11,22-27,32-34,42,44-45,57,64H,12-21,28-31H2,1-5H3,(H,55,56)(H,58,63)/t34?,42-,44+,45-,52?/m0/s1.
What are the key properties of 2-[(3-fluoro-1H-pyrrolo[2,3-b]pyridin-5-yl)oxy]-N-[[(3S)-3-(4-hydroxy-4-methylcyclohexyl)-5-nitro-3,4-dihydro-2H-1,4-benzoxazin-7-yl]sulfonyl]-4-[2-[(3R,4S)-3-(2-propan-2-ylphenyl)-1-propan-2-ylsulfonylpiperidin-4-yl]-2,7-diazaspiro[3.5]nonan-7-yl]benzamide?
2-[(3-fluoro-1H-pyrrolo[2,3-b]pyridin-5-yl)oxy]-N-[[(3S)-3-(4-hydroxy-4-methylcyclohexyl)-5-nitro-3,4-dihydro-2H-1,4-benzoxazin-7-yl]sulfonyl]-4-[2-[(3R,4S)-3-(2-propan-2-ylphenyl)-1-propan-2-ylsulfonylpiperidin-4-yl]-2,7-diazaspiro[3.5]nonan-7-yl]benzamide has a molecular weight of 1057.28 g/mol, XLogP of 8.26, 13 rotatable bonds, 4 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(3-fluoro-1H-pyrrolo[2,3-b]pyridin-5-yl)oxy]-N-[[(3S)-3-(4-hydroxy-4-methylcyclohexyl)-5-nitro-3,4-dihydro-2H-1,4-benzoxazin-7-yl]sulfonyl]-4-[2-[(3R,4S)-3-(2-propan-2-ylphenyl)-1-propan-2-ylsulfonylpiperidin-4-yl]-2,7-diazaspiro[3.5]nonan-7-yl]benzamide is sourced from PubChem (CID 168761263), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).